RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA
Public ClinicalTrials.gov record NCT06146101. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II/III, Randomised, Double-Blind Clinical Trial to Determine the Safety and Efficacy of IHL-42X in Subjects With Obstructive Sleep Apnoea Who Are Intolerant, Non-Compliant, or Naïve to Positive Airway Pressure
Study identification
- NCT ID
- NCT06146101
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Incannex Healthcare Ltd
- Industry
- Enrollment
- 560 participants
Conditions and interventions
Conditions
Interventions
- IHL-42X Low Dose Drug
- IHL-42X High Dose Drug
- Placebo Drug
- IHL-42X (Optimal Dose) Drug
- Dronabinol Drug
- Acetazolamide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 1, 2024
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Apr 19, 2025
2024 – 2026
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Exalt Clinical Research | Chula Vista | California | 91910 | — |
| CenExel CNS- Los Alamitos | Long Beach | California | 90806 | — |
| Pacific Clinical Research Medical Group | Upland | California | 91786-4985 | — |
| Clinical Neuroscience Solutions, Inc. (CNS Healthcare of Jacksonville) | Jacksonville | Florida | 32256 | — |
| Clinical Neuroscience Solutions, Inc. (CNS Healthcare of Orlando) | Orlando | Florida | 32806 | — |
| Teradan Clinical Trials | Valrico | Florida | 33596-8262 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409-3401 | — |
| NeuroTrials Research, Inc. | Atlanta | Georgia | 30328 | — |
| Tandem Clinical Research, LLC | Marrero | Louisiana | 70072 | — |
| Centennial Medical Group | Elkridge | Maryland | 21075-6434 | — |
| Meridian Clinical Research, LLC | Rockville | Maryland | 20854 | — |
| Henderson Clinical Trials,LLC | Henderson | Nevada | 89052-5016 | — |
| Advanced Respiratory and Sleep Medicine, PLLC | Huntersville | North Carolina | 28078 | — |
| CTI Clinical Trial and Consulting Services | Cincinnati | Ohio | 45212 | — |
| Intrepid Research | Cincinnati | Ohio | 45245-4501 | — |
| Velocity Clinical Research - Anderson | Anderson | South Carolina | 29621 | — |
| Velocity Clinical Research - Greenville | Greenville | South Carolina | 29615 | — |
| Clinical Neuroscience Solutions, Inc. (CNS Healthcare of Memphis) | Memphis | Tennessee | 38119 | — |
| FutureSearch Trials | Austin | Texas | 78731 | — |
| FutureSearch Trials of Dallas, LP | Dallas | Texas | 75231-3442 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06146101, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06146101 live on ClinicalTrials.gov.